Le Lézard
Classified in: Covid-19 virus

Cough, Cold and Allergy (Hay Fever) Remedies in Australia: COVID-19 Pandemic is Having a Polarising Demand in 2021 - ResearchAndMarkets.com


The "Cough, Cold and Allergy (Hay Fever) Remedies in Australia" report has been added to ResearchAndMarkets.com's offering.

The pandemic is having a polarising impact on demand for cold, cough and allergy (hay fever) remedies in 2021. While COVID-19 measures including social distancing rules, use of protective face masks and hand sanitisers were put in place to limit the spread of the virus in Q1 and Q2 2021, these restrictions have also been limiting the spread of common influenza symptoms in Australia.

The report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage:

Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage:

Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Key report benefits:

Key Topics Covered:

HEADLINES

2021 DEVELOPMENTS

PROSPECTS AND OPPORTUNITIES

CATEGORY DATA

CONSUMER HEALTH IN AUSTRALIA

EXECUTIVE SUMMARY

MARKET INDICATORS

MARKET DATA

For more information about this report visit https://www.researchandmarkets.com/r/xzu25p

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


These press releases may also interest you

19 avr 2024
Voxtur Analytics Corp. , a North American technology company creating a more transparent and accessible real estate lending ecosystem, is pleased to announce that it has engaged the services of ICP Securities Inc. ("ICP") to provide automated market...

19 avr 2024
On April 19, 2024, the board of directors of Portland General Electric Company declared a quarterly common stock dividend of $0.50 per share, representing an increase of 5.3%, or $0.10 per share, on an annualized basis. The company's dividend is...

19 avr 2024
Adyton Resources Corporation  ("Adyton" or the "Company") announces it has closed its previously announced non-brokered private placement offering, pursuant to which it has issued 50,000,000 common shares of the Company ("Shares") at a price of...

19 avr 2024
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

19 avr 2024
Lion Group Holding Ltd. ("Lion" or "the Company") , the operator of an all-in-one trading platform that offers a wide spectrum of products and services, today announced that on April 18, 2024, it received a delinquency notification letter from the...

19 avr 2024
Cosmos Health Inc. ("Cosmos Health" or the "Company'') , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor...



News published on and distributed by: